Health Minister, Mark Butler has launched the new Australian Evidence-Based Clinical Practice Guideline for ADHD. The Minister’s launch caps off a remarkable two-year collaboration between clinical professionals, researchers, and people with lived experience.
The Guideline provides a summary of scientific evidence and advice on the identification, diagnosis, support and treatment options for ADHD, including options with, and without, the use of medication.
“This Guideline sets the benchmark for best-practice evidence-based assessment, treatment and support for people living with ADHD, and also lays a roadmap for ADHD clinical practice, research and policy,” said Mr Butler
The Australian Government provided $1.5 million to the Australian ADHD Professionals Association to develop the Guideline with a focus on everyday functioning and quality of life, based on age, gender, culture, setting and geography.
Mr Butler heralded the Guideline as an important tool to help inform clinicians, including medical and allied health professionals, nurses, pharmacists, and those involved in the support of people with ADHD such as educators and families, to drive improvements in care across Australia.
“This Guideline could be a game-changer for people living with ADHD, especially as it is based on the best available evidence, including multidisciplinary clinical expertise and input from people with lived experience. Earlier diagnosis, better treatment and care will help improve the lives of people living with ADHD so they can reach their full potential.”
